Welcome to our new Instron Community Blog hosted by Instron. It is a compilation of the freshest, brightest, most-talented minds that Instron has to offer. The world of materials science is so vast and encompasses the broadest range of industries, materials, and challenges that no one person can possibly possess all the knowledge required to be the resident expert – or master of materials science. It takes a small army behind the scenes collaborating and sharing technical know-how, experiences, and ideas to present the most accurate, relevant, and timely information to you – our readers.

We invite you to tell us who you are, share your stories and talk about your experiences. Join the Instron Community.

Friday, October 11, 2013

Who Should Be First in Line to Receive a Transplant Organ?

Tissue Engineering and Regenerative Medicine therapies are seeking to abolish this question.  Researchers around the globe are developing new scaffolds (materials on which to grow cells), identifying appropriate cell lines to use for specific tissues, and perfecting the recipe for putting the two together to grow new tissues and organs for transplant.   Instron is a part of this recipe.  Our mechanical systems and bioreactor chambers provide a controlled environment to develop new tissues and organs. The bioreactor chamber provides a closed, sterile location to house the sample; while the mechanical forces can be used to send mechanical cues to the cells to assist with differentiation, characterize native tissue and scaffolds, or evaluate tissue engineered products. Read our TERM (Tissue Engineering & Regenerative Medicine) Update to learn more about Instron's activity in this market. Stay tuned for more application updates.

Photo courtesy of Dr. Harlad Ott @ Massachusetts General Hospital:  Lungs being decellularized in an Instron TGT bioreactor chamber.

No comments: